Collplant Biotechnologies LTCLGN
13F holders, Q1 2024 (March 31)12holders
1famous investor
$5.36avg. 13F price*
At the end of Q1 2024, 12 institutions reported holding Collplant Biotechnologies LT (CLGN) in their 13F filings. The largest holders were Pinnacle Associates Ltd. ($2.8M), Villere St Denis J & Co. LLC ($2.0M) and Roumell Asset Management, LLC ($1.7M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Collplant Biotechnologies LT
- CUSIP
- M2R51X116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $26K |
| Exits | 5 | $164K |
Ownership 12 holders
| Pinnacle Associates Ltd. | 0.04% | Add +13.3% | 530,455 | $2.8M |
| Villere St Denis J & Co. LLC | 0.16% | Add +1.6% | 366,967 | $2.0M |
| Roumell Asset Management, LLC | 3.20% | Reduce -27.1% | 315,288 | $1.7M |
| Brown Advisory Inc. | 0.00% | Add +59.7% | 119,536 | $640K |
| Benjamin F. Edwards & Company, Inc. | 0.00% | Add +0.6% | 50,450 | $272K |
| Citadel Advisors | 0.00% | Add +95.9% | 13,193 | $71K |
| Bank of America Corp. | 0.00% | No change | 7,300 | $39K |
| UBS Group AG | 0.00% | New | 4,780 | $26K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 3,600 | $19K |
| National Bank of Canada | 0.00% | No change | 250 | $2K |
| Qube Research & Technologies Ltd | 0.00% | No change | 6 | $32 |
| Morgan Stanley | 0.00% | No change | 1 | $9 |
"% of holder's portfolio" is CLGN's weight in each manager's 13F, not the share of Collplant Biotechnologies LT the manager owns.